Rising Biogenetics Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 16-07-2024
- Paid Up Capital ₹ 2.50 M
as on 16-07-2024
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.00 M
as on 16-07-2024
- Revenue -21.47%
(FY 2023)
- Profit -57.42%
(FY 2023)
- Ebitda -6.94%
(FY 2023)
- Net Worth 2.99%
(FY 2023)
- Total Assets -10.66%
(FY 2023)
About Rising Biogenetics
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹7.00 M.
Surendra Patel, Ravindra Engla, and Vinod Patil serve as directors at the Company.
- CIN/LLPIN
U24100MP2011PTC027035
- Company No.
027035
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Nov 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Sanawad, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Rising Biogenetics Private Limited offer?
Rising Biogenetics Private Limited offers a wide range of products and services, including Seeds and Plant Saplings, Fruit Seeds, Mosquito & Insect Repellent, Insect Trap, Hybrid Seeds, Fertilizers and Soil Additives, Fertilizer, Pheromone Trap, Fruit Fly Trap, Soil Conditioner.
Who are the key members and board of directors at Rising Biogenetics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surendra Patel  | Director | 01-Nov-2011 | Current |
| Ravindra Engla | Director | 04-Aug-2012 | Current |
| Vinod Patil | Director | 01-Nov-2011 | Current |
Financial Performance of Rising Biogenetics.
Rising Biogenetics Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.47% decrease. The company also saw a substantial fall in profitability, with a 57.42% decrease in profit. The company's net worth moved up by a moderate rise of 2.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rising Biogenetics?
In 2023, Rising Biogenetics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rising Flora Biotech Private LimitedActive 16 years 11 monthsSurendra Patel and Vinod Patil are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 03 Jul 2015 | ₹7.00 M | Open |
How Many Employees Work at Rising Biogenetics?
Unlock and access historical data on people associated with Rising Biogenetics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rising Biogenetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rising Biogenetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
